M
Myrlene A. Staten
Researcher at National Institutes of Health
Publications - 39
Citations - 3536
Myrlene A. Staten is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Type 2 diabetes & Prediabetes. The author has an hindex of 18, co-authored 35 publications receiving 2988 citations. Previous affiliations of Myrlene A. Staten include Stanford University & Amgen.
Papers
More filters
Journal ArticleDOI
Perioperative safety in the longitudinal assessment of bariatric surgery.
David R. Flum,Steven H. Belle,Wendy C. King,Abdus S. Wahed,Paul D. Berk,William C. Chapman,Walter J. Pories,Anita P. Courcoulas,Carol A. McCloskey,James E. Mitchell,Emma J. Patterson,Alfons Pomp,Myrlene A. Staten,Susan Z. Yanovski,Richard C. Thirlby,Bruce M. Wolfe +15 more
TL;DR: The overall risk of death and other adverse outcomes after bariatric surgery was low and varied considerably according to patient characteristics, andExtreme values of body-mass index were significantly associated with an increased risk of the composite end point, whereas age, sex, race, ethnic group, and other coexisting conditions were not.
Journal ArticleDOI
Vitamin D Supplementation and Prevention of Type 2 Diabetes
Anastassios G. Pittas,Bess Dawson-Hughes,Patricia R. Sheehan,James H. Ware,William C. Knowler,Vanita R. Aroda,Irwin G. Brodsky,Lisa Ceglia,Chhavi Chadha,Ranee Chatterjee,Cyrus Desouza,Rowena J. Dolor,John P. Foreyt,Paul J. Fuss,Adline Ghazi,Daniel S. Hsia,Karen C. Johnson,Sangeeta R. Kashyap,Sun H. Kim,Erin S. LeBlanc,Michael R. Lewis,Emilia Liao,Lisa M. Neff,Jason Nelson,Patrick O'Neil,Patrick O'Neil,Jean Park,Anne L. Peters,Lawrence S. Phillips,Richard E. Pratley,Philip Raskin,Neda Rasouli,David C. Robbins,Clifford J. Rosen,Ellen M Vickery,Myrlene A. Staten +35 more
TL;DR: Among persons at high risk for type 2 diabetes not selected for vitamin D insufficiency, vitamin D3 supplementation at a dose of 4000 IU per day did not result in a significantly lower risk of diabetes than placebo.
Journal ArticleDOI
Long-term Outcomes of Bariatric Surgery: A National Institutes of Health Symposium
Anita P. Courcoulas,Susan Z. Yanovski,Denise E. Bonds,Thomas L. Eggerman,Mary Horlick,Myrlene A. Staten,David Arterburn +6 more
TL;DR: High-quality evidence shows that bariatric surgical procedures result in greater weight loss than nonsurgical treatments and are more effective at inducing initial type 2 diabetes mellitus remission in obese patients.
Journal ArticleDOI
Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study.
Paul Zimmet,Allison M. Hodge,Margery Nicolson,Myrlene A. Staten,Maximilian de Courten,Jason Moore,Andrew Morawiecki,John A. Lubina,Gregory Collier,George Alberti,Gary K. Dowse +10 more
TL;DR: The strong relation of leptin with obesity is consistent with leptin production being proportional to mass of adipose tissue, but the independent association with insulin concentration suggests a possible role in insulin resistance or hyperinsulinaemia.
Journal ArticleDOI
Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
David M. Nathan,John B. Buse,Steven E. Kahn,Heidi Krause-Steinrauf,Mary E. Larkin,Myrlene A. Staten,Deborah J. Wexler,John M. Lachin +7 more
TL;DR: This pragmatic, unmasked clinical trial aims to compare commonly used diabetes medications, when combined with metformin, on glycemia-lowering effectiveness and patient-centered outcomes and provide guidance to clinicians about the most appropriate medications to treat T2DM.